Selegiline’s Role in Enhancing Lifespan

Table of contents

Lifespan extension and healthy aging have become increasingly important as the global population ages. Researchers are actively seeking innovative solutions to promote longevity and improve overall well-being. One compound that has garnered attention is Selegiline, a selective monoamine oxidase B (MAO-B) inhibitor. Initially developed to treat Parkinson’s disease and major depressive disorder, Selegiline has shown promise in enhancing cognitive function and motor control.

Researchers have been exploring Selegiline’s potential to enhance longevity, sparking extensive studies. Findings indicate that Selegiline may support cellular well-being and resilience by inhibiting MAO-B, thereby reducing oxidative stress and inflammation – primary contributors to aging. Examining the link between Selegiline and anti-aging can yield valuable insights into its potential benefits. Don’t wait any longer, and buy Selegiline to boost your daily life, to support overall well-being and longevity.ย 

Understanding Selegiline and Its Biological Function

Selegiline, also known as Deprenyl, is a selective monoamine oxidase B (MAO-B) inhibitor. By inhibiting MAO-B, Selegiline increases dopamine levels, a neurotransmitter crucial for motor control and mood regulation. This makes Selegiline effective in treating Parkinson’s disease, alleviating symptoms like tremors, rigidity, and bradykinesia.

Selegiline’s neuroprotective properties have sparked interest in its anti-aging potential. By inhibiting MAO-B, Selegiline reduces oxidative stress and inflammation in the brain, contributing to neurodegenerative diseases. Researchers are exploring Selegiline’s potential in promoting extended brain health and prolonged life.

Scientific Research on Selegiline and Lifespan Extension

Numerous scientific studies have investigated the potential of Selegiline to extend lifespan, with promising results.

Early Longevity Studies in Animals 

Early longevity studies in animals have demonstrated the potential of low-dose Selegiline to prolong life. Dr. Joseph Knoll’s pioneering work in the 1980s showed that low-dose Deprenyl (Selegiline) increased the average lifespan in rats by 34%. Subsequent studies confirmed these findings, with low-dose Selegiline increasing average lifespan by 20-30% and improving healthspan markers. These studies highlight the potential of Selegiline to promote healthy aging and extend lifespan.

Key findings:

  • 20-30% increase in average lifespan
  • Improved healthspan markers: reduced oxidative stress and inflammation
  • Potential to prolong life by minimizing age-related diseases
  • Effective doses: 0.25-0.5 mg/kg Selegiline

Selegiline in Non-Rodent Models

Selegiline has shown promise in non-rodent models, including dogs and primates. In canine studies, Selegiline improved cognitive function and reduced age-related behavioral changes. In rhesus macaques, Selegiline increased dopamine levels and enhanced motor function. These findings have translational relevance to human aging, suggesting Selegiline’s potential for treating age-related diseases, such as Parkinson’s and cognitive decline, in humans.

How Selegiline Supports Longevity in Humans

As humans age, dopamine levels naturally decline, while monoamine oxidase (MAO) activity increases, leading to oxidative stress and inflammation in the brain. Selegiline, a selective MAO-B inhibitor, plays a crucial role in preserving brain function and potentially slowing age-related decline. By inhibiting MAO-B, Selegiline increases dopamine levels, promoting improved mood, cognition, and energy levels over time.

Potential Benefits of Selegiline:

  • Improved mood: Enhanced dopamine levels can alleviate symptoms of depression and anxiety.
  • Cognitive function: Increased dopamine can improve focus, attention, and memory.
  • Energy levels: Selegiline’s neuroprotective effects may help maintain energy levels and reduce fatigue.
  • Selegiline increases life expectancy: Selegiline’s ability to reduce oxidative stress and inflammation may contribute to a longer and healthier lifespan.

Low-Dose Selegiline and Long-Term Use

Low-dose Selegiline, ranging from 1-5 mg daily, is significantly lower than therapeutic doses for Parkinson’s and depression. Researchers use lower doses for longevity and anti-aging to avoid overstimulation. The goal is to support brain health and neuroprotection without over-activating the brain’s reward system. This approach follows the principle of “hormesis,” where a low-level stressor activates cellular pathways promoting resilience and longevity. By optimizing the dose, researchers can harness Selegiline’s benefits for longevity while minimizing risks, striking a balance between brain health support and adverse effect mitigation.

Comparing Selegiline with Other Longevity Compounds

Selegiline stands out from other studied life-extension agents, such as rapamycin, metformin, and resveratrol, due to its unique mechanism of action. While these agents primarily target metabolic pathways, Selegiline focuses on neurological pathways, specifically inhibiting monoamine oxidase B (MAO-B) to increase dopamine levels and promote neuroprotection.

Comparison with other life-extension agents:

  • Rapamycin: Slows cell growth, helping cells live longer.
  • Metformin: Regulates blood sugar and fat, promoting healthy metabolism.
  • Resveratrol: Activates pathways that fight aging, inflammation, and disease.
  • Selegiline: Boosts brain health by increasing dopamine and protecting brain cells.

Combining Selegiline with metabolic-targeting agents may provide a comprehensive approach to promoting healthy aging and extending lifespan.

FAQs

How does Selegiline enhance lifespan?

Selegiline enhances lifespan by inhibiting MAO-B, increasing dopamine, and promoting neuroprotection, reducing oxidative stress and inflammation.

What is the best dose of Selegiline for longevity?

The optimal dose of Selegiline for longevity is 1-5 mg/day, with 2.5 mg/day being a commonly recommended dose for anti-aging benefits. But consult your healthcare professional. 

Is there human research showing Selegiline increases life expectancy?

Human research is limited, but early studies suggest Selegiline’s neuroprotective effects may support a longer health span and potential longevity.

Can Selegiline be taken long-term for anti-aging purposes?

Selegiline is generally considered safe for long-term use, but monitoring and medical supervision are recommended for anti-aging purposes.

Is Selegiline safe for healthy adults without Parkinsonโ€™s disease?

Selegiline is generally considered safe for healthy adults without Parkinson’s, but individual tolerance and monitoring are essential since it is not FDA-approved.


References 

  1. Novotney, A. (2011, December 1). The real secrets to a longer life. Monitor on Psychology, 42(11). https://www.apa.org/monitor/2011/12/longer-life
  2. Hamid Shokati Basir, Naser Mirazi, Alireza Komaki, Behnam Mohamadpour & Abdolkarim Hosseini. (2024) Selegiline Improves Cognitive Impairment in the Rat Model of Alzheimerโ€™s Disease. Molecular Neurobiologyhttps://www.tandfonline.com/doi/abs/10.1080/01616412.2022.2129761
  3. Knoll J. Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain. CNS Drug Rev. 2001 Fall;7(3):317-45. doi: 10.1111/j.1527-3458.2001.tb00202.x. PMID: 11607046; PMCID: PMC6494119.https://pmc.ncbi.nlm.nih.gov/articles/PMC6494119
  4. Tรกbi T, Vรฉcsei L, Youdim MB, Riederer P, Szรถkล‘ ร‰. Selegiline: a molecule with innovative potential. J Neural Transm (Vienna). 2020 May;127(5):831-842. doi: 10.1007/s00702-019-02082-0. Epub 2019 Sep 27. PMID: 31562557; PMCID: PMC7242272.https://pmc.ncbi.nlm.nih.gov/articles/PMC7242272
  5. Soliman, Ghada, Hashem, Ghada, Fawzy, Monica, Ibrahim, Walaa, 2019/11/15, Neuroprotective Effects of Metformin Versus Selegiline on Parkinsonโ€™s Disease Model By Reserpine through the Interrelation of ฮฑ Synuclein and Antioxidants on Behavioral Changes in Rats, VL  – 9, DO  – 10.32527/2019/101450, Egyptian Journal of Basic and Clinical Pharmacology.https://www.researchgate.net/publication/352548581_Neuroprotective_Effects_of_Metformin_Versus_Selegiline_on_Parkinson’s_Disease_Model_By_Reserpine_through_the_Interrelation_of_a_Synuclein_and_Antioxidants_on_Behavioral_Changes_in_Rats/citation/download

Table of contents

Authors

More articles

Selegiline Enhances Libido: How It Can Help You

Apr 2, 2025 Articles

Selegiline’s Role in Enhancing Lifespan

Apr 2, 2025 Articles

Selegiline for ADHD: Is It the Solution You Are Looking For?

Apr 2, 2025 Articles

Rasagiline vs Selegiline: Which One is Better For You?

Apr 2, 2025 Articles

Does Selegiline Increase Dopamine?

Apr 2, 2025 Articles

Related products

Save with sets

Unlock savings on bundles and elevate your online experience today!